Found: 14
Select item for more details and to access through your institution.
Artemisinin-type drugs for the treatment of hematological malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Starting dose selection and dose escalation for oncology small molecule first-in-patient trials: learnings from a survey of FDA-approved drugs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 23, doi. 10.1007/s00280-020-04202-0
- By:
- Publication type:
- Article
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 31, doi. 10.1007/s00280-020-04173-2
- By:
- Publication type:
- Article
An investigation into possible interactions among four vascular epidermal growth factor receptor-tyrosine kinase inhibitors with gefitinib.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 65, doi. 10.1007/s00280-020-04174-1
- By:
- Publication type:
- Article
Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 73, doi. 10.1007/s00280-020-04177-y
- By:
- Publication type:
- Article
Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
MiniPDX-guided postoperative anticancer treatment can effectively prolong the survival of patients with hepatocellular carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 1, p. 135, doi. 10.1007/s00280-020-04201-1
- By:
- Publication type:
- Article
Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses.
- Published in:
- 2021
- By:
- Publication type:
- corrected article